Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03833674 |
Other study ID # |
IRB201802672 |
Secondary ID |
W81XWH-18-1-0718 |
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
August 15, 2020 |
Est. completion date |
February 20, 2024 |
Study information
Verified date |
May 2024 |
Source |
University of Florida |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Acute intermittent hypoxia (AIH) involves short (~1-2min) bouts of breathing low oxygen air
to stimulate spinal neuroplasticity. Studies in rodents and humans indicate that AIH improves
motor function after spinal cord injury (SCI). This study will use a double blind, cross-over
design to test if the combination of AIH and respiratory strength training improves breathing
function more than either approach alone in adults with chronic SCI.
Description:
Spinal cord injury (SCI) disrupts neural pathways to respiratory motor neurons, causing
muscle paralysis and decreased breathing capacity. Since respiratory impairment is the major
cause of illness and death with SCI, it is critical to devise new strategies to restore
breathing function.
Repetitive exposure to brief episodes of low oxygen (acute intermittent hypoxia or AIH) has
demonstrated to increase respiratory function in humans with chronic SCI. Additionally
pre-clinical studies demonstrate that AIH-induced functional benefits are enhanced by
combining AIH with task-specific training. The investigator's central hypothesis is that
combined daily AIH (dAIH) and respiratory strength training will elicit greater and more
sustained gains in respiratory function than either treatment alone in people with chronic
SCI.
This study is a double-blind, randomized, cross-over design where participants will complete
4 random-ordered blocks, consisting of a 5-day intervention followed by a 3-week washout
period, during which 1-day, 3-day, and 1-week post-tests will be conducted. Participants will
include 53 adults with chronic, incomplete SCI with >20% respiratory impairment based on
maximal inspiratory or expiratory pressure generation.